Results 31 to 40 of about 7,288 (241)

Mucoviscidose et traitements inhalés : quoi de neuf en 2013 ? [PDF]

, 2014
Depuis quelques années, de nouvelles molécules administrées par voie inhalée et de nouveaux dispositifs d’inhalation sont apparus pour le traitement de la mucoviscidose.
Reychler, Gregory, GRAM (Groupe aérosols et mucoviscidose de la Société française de mucoviscidose), Desmazes-Dufeu, Nadine, Bassinet, Laurence, Delaisi, Bertrand, Vecellio, Laurent, Chedevergne, Frédérique, Dubus, Jean-Christophe   +7 more
core   +1 more source

Quality of care in cystic fibrosis: assessment protocol of the French QIP PHARE-M

Orphanet Journal of Rare Diseases, 2018
Background The PHARE-M care quality improvement program, modeled on the US Cystic Fibrosis Quality Improvement Program, was introduced at 14 cystic fibrosis centers (CFCs) in the French Cystic Fibrosis Network between 2011 and 2013.
Dominique Pougheon Bertrand, Emmanuel Nowak, Clémence Dehillotte, Lydie Lemmonier, Gilles Rault   +4 more
doaj   +1 more source

Putting bicarbonate on the spot: pharmacological insights for CFTR correction in the airway epithelium

Frontiers in Pharmacology, 2023
Introduction: Cystic fibrosis (CF) is caused by defective Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) proteins. CFTR controls chloride (Cl−) and bicarbonate (HCO3−) transport into the Airway Surface Liquid (ASL). We investigated the impact
Miroslaw Zajac, Miroslaw Zajac, Miroslaw Zajac, Miroslaw Zajac, Agathe Lepissier, Agathe Lepissier, Agathe Lepissier, Elise Dréano, Elise Dréano, Elise Dréano, Benoit Chevalier, Benoit Chevalier, Benoit Chevalier, Aurélie Hatton, Aurélie Hatton, Aurélie Hatton, Mairead Kelly-Aubert, Mairead Kelly-Aubert, Mairead Kelly-Aubert, Daniela Guidone, Gabrielle Planelles, Aleksander Edelman, Aleksander Edelman, Aleksander Edelman, Emmanuelle Girodon, Emmanuelle Girodon, Alexandre Hinzpeter, Alexandre Hinzpeter, Alexandre Hinzpeter, Gilles Crambert, Iwona Pranke, Iwona Pranke, Iwona Pranke, Luis. J. V. Galietta, Isabelle Sermet-Gaudelus, Isabelle Sermet-Gaudelus, Isabelle Sermet-Gaudelus, Isabelle Sermet-Gaudelus   +37 more
doaj   +1 more source

Early chest CT abnormalities to predict the subsequent occurrence of chronic lung allograft dysfunction

Insights into Imaging, 2023
Introduction Chronic lung allograft dysfunction (CLAD) can take two forms: bronchiolitis obliterans syndrome (BOS) or restrictive allograft syndrome (RAS).
Paul Habert, Elsa Chetrit, Benjamin Coiffard, Fabienne Bregeon, Pascal Thomas, Anderson Loundou, Julien Bermudez, Martine Reynaud-Gaubert, Jean-Yves Gaubert   +8 more
doaj   +1 more source

Therapeutic Approaches for Patients with Cystic Fibrosis Not Eligible for Current CFTR Modulators

Cells, 2021
Cystic fibrosis is a severe autosomal recessive disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene encoding the CFTR protein, a chloride channel expressed in many epithelial cells.
Isabelle Fajac, Isabelle Sermet
doaj   +1 more source

Mucoviscidose : l’espace bleu entre les nuages ? [PDF]

, 2013
Découvrir un traitement plus fondamental de la mucoviscidose est nécessaire, même si n’en profiteront pleinement que les patients dont les poumons auront pu être largement préservés jusque là.
Leonard, Anissa, A. Leonard, Lebecque, Patrick, P. Lebecque, T. Leal, Leal, Teresinha   +5 more
core   +1 more source

Registre Français de la Mucoviscidose. Bilan des données 2016 [PDF]

, 2017
ObjectifsL’association Vaincre la Mucoviscidose a mis en place en 1992 un Observatoire National de la Mucoviscidose (ONM) ayant les objectifs suivants :– améliorer la connaissance des caractéristiques médicales et sociales,– mieux appréhender le coût ...
Lemonnier, Lydie, Dehillotte, Clémence, Bellis, Gil   +2 more
core   +2 more sources

La mucoviscidose en héritage [PDF]

, 2021
La mucoviscidose, due à une mutation du gène CFTR, affecte 1 naissance sur 4 500 en France et 1 naissance sur 3 000 en Bretagne. Le Finistère est l’une des régions où la fréquence de la maladie est la plus importante au monde. Malgré d’importants progrès
Rollet, Catherine, Pellen, Nadine
core   +3 more sources

Prevalência da mutação ΔF508 no gene cystic fibrosis transmembrane conductance regulator em pacientes com fibrose cística em um centro de referência no Brasil

Jornal de Pediatria, 2012
OBJETIVO: Verificar a presença da mutação ΔF508 no gene cystic fibrosis transmembrane conductance regulator na população de pacientes com fibrose cística, diagnosticados pelo teste de sódio e cloro no suor, em acompanhamento no Ambulatório de Pneumologia
Andréia Marisa Bieger, Fernando Augusto de Lima Marson, Carmen Sílvia Bertuzzo   +2 more
doaj   +1 more source

Role of Host and Bacterial Lipids in Pseudomonas aeruginosa Respiratory Infections

Frontiers in Immunology, 2022
The opportunistic pathogen Pseudomonas aeruginosa is one of the most common agents of respiratory infections and has been associated with high morbidity and mortality rates. The ability of P. aeruginosa to cause severe respiratory infections results from
Pamella Constantino-Teles, Albane Jouault, Lhousseine Touqui, Alessandra Mattos Saliba   +3 more
doaj   +1 more source